Healthcare provider profile · identity verified

Marcus D Powers, MD

Family Practice · LOCK HAVEN, PA · NPI 1982195442

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	234	73
Lisinopril	Lisinopril	150	52
Gabapentin	Gabapentin	132	46
Omeprazole	Omeprazole	124	43
Lorazepam	Lorazepam	116	60
Levothyroxine Sodium	Levothyroxine Sodium	110	35
Fluticasone Propionate	Fluticasone Propionate	82	31
Prednisone	Prednisone	81	63
Amlodipine Besylate	Amlodipine Besylate	78	32
Pantoprazole Sodium	Pantoprazole Sodium	76	23
Metoprolol Succinate	Metoprolol Succinate	73	24
Duloxetine Hcl	Duloxetine Hcl	71	27
Sertraline Hcl	Sertraline Hcl	71	17
Tramadol Hcl	Tramadol Hcl	65	34
Hydrochlorothiazide	Hydrochlorothiazide	64	22
Albuterol Sulfate Hfa	Albuterol Sulfate	63	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	25
Tamsulosin Hcl	Tamsulosin Hcl	61	18
Metformin Hcl	Metformin Hcl	58	18
Losartan Potassium	Losartan Potassium	53	17
Potassium Chloride	Potassium Chloride	52	18
Pregabalin	Pregabalin	49	18
Eliquis	Apixaban	47	15
Simvastatin	Simvastatin	46	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	15
Furosemide	Furosemide	38	18
Tizanidine Hcl	Tizanidine Hcl	37	16
Zolpidem Tartrate	Zolpidem Tartrate	37	16
Alprazolam	Alprazolam	36	14
Glipizide Er	Glipizide	35	suppressed
Trazodone Hcl	Trazodone Hcl	35	12
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Famotidine	Famotidine	34	15
Finasteride	Finasteride	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	17
Azithromycin	Azithromycin	32	26
Jardiance	Empagliflozin	30	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	25
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	16
Rosuvastatin Calcium	Rosuvastatin Calcium	29	14
Allopurinol	Allopurinol	28	11
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	22
Ezetimibe	Ezetimibe	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Atenolol	Atenolol	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Jantoven	Warfarin Sodium	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Ozempic	Semaglutide	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Naproxen	Naproxen	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Ondansetron Odt	Ondansetron	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Diazepam	Diazepam	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error